PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2015 | 61 | 2 |
Tytuł artykułu

The efficacy of oral ivermectin vs. sulfur 10% ointment for the treatment of scabies

Treść / Zawartość
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
Human scabies is caused by an infection of the skin by the human itch mite (Sarcoptes scabiei var. hominis). There are different medications for the treatment of scabies. This study aimed at comparing the efficacy and safety of oral ivermectin vs. sulfur 10% ointment for the treatment of scabies. In total, 420 patients with scabies were enrolled, and randomized into two groups: the first group received a single dose of oral ivermectin 200 μg/kg body weight, and the second group received sulfur 10% ointment and were told to apply this for three successive days. Treatment was evaluated at intervals of 2 and 4 weeks, and if there was treatment failure at the 2-week follow-up, treatment was repeated. A single dose of ivermectin provided a cure rate of 61.9% at the 2-week follow-up, which increased to 78.5% at the 4-week follow-up after repeating the treatment. Treatment with single applications of sulfur 10% ointment was effective in 45.2% of patients at the 2-week follow-up, which increased to 59.5% at the 4-week follow-up after this treatment was repeated. A single dose of ivermectin was as effective as single applications of sulfur 10% ointment at the 2-week follow-up. After repeating the treatment, ivermectin was superior to sulfur 10% ointment at the 4-week follow up. The delay in clinical response with ivermectin suggests that it may not be effective against all the stages in the life cycle of the parasite.
Słowa kluczowe
Wydawca
-
Rocznik
Tom
61
Numer
2
Opis fizyczny
p.79-84,ref.
Twórcy
autor
  • Tabriz University of Medical Sciences, Aras Branch, Tabriz, Iran
autor
  • Young Researchers and Elite Club, Qaemshahr Branch, Islamic Azad University, Qaemshahr, Iran
Bibliografia
  • [1] Mounsey K.E., Murray H.C., Bielefeldt-Ohmann H., Pasay C., Holt D.C., Currie B.J. et al. 2015. Prospective study in a porcine model of Sarcoptes scabiei indicates the association of Th2 and Th17 pathways with the clinical severity of scabies. PLoS Neglected Tropical Diseases 9: e0003498.
  • [2] Rosamilia L.L. 2014. Scabies. Seminars in Cutaneous Medicine and Surgery 33: 106-109.
  • [3] Goldust M., Rezaee E., Raghifar R., Hemayat S. 2014. Comparing the efficacy of oral ivermectin vs malation 0.5% lotion for the treatment of scabies. Skinmed 12: 284-287.
  • [4] Seebaluck R., Gurib-Fakim A., Mahomoodally F. 2015. Medicinal plants from the genus Acalypha (Euphorbiaceae) – a review of their ethno pharma - cology and phytochemistry. Journal of Ethnopharma - cology 159:137-157.
  • [5] Goldust M., Rezaee E., Raghiafar R. 2014. Topical ivermectin versus crotamiton cream 10% for the treatment of scabies. International Journal of Dermatology 53: 904-908.
  • [6] Feldmeier H. 2014. Treatment of parasitic skin diseases with dimeticones a new family ofcompounds with a purely physical mode of action. Tropical Medicine and Health 42(2 Suppl): 15-20.
  • [7] Goldust M., Rezaee E., Raghifar R., Hemayat S. 2013. Treatment of scabies: the topical ivermectin vs. permethrin 2.5% cream. Annals of Parasitology 59: 79-84.
  • [8] Murakonda P., Yazdanbaksh K., Dharmarajan T.S. 2014. Scabies in the nursing home, misdiagnosis means costs, and embarrassment: story of a centenarian smitten by scabies! Journal of the American Medical Directors Association 15: 74-75.
  • [9] Goldust M., Rezaee E. 2013. Comparative trial of oral ivermectin versus sulfur 8% ointment for the treatment of scabies. Journal of Cutaneous Medicine and Surgery 17: 299-300.
  • [10] Haar K., Romani L., Filimone R., Kishore K., Tuicakau M., Koroivueta J. et al. 2014. Scabies community prevalence and mass drug administration in two Fijian villages. International Journal of Dermatology 53: 739-745.
  • [11] Goldust M., Rezaee E., Raghifar R., Naghavi- Behzad M. 2013. Ivermectin vs. lindane in the treatment of scabies. Annals of Parasitology 59: 37- 41.
  • [12] Birry A., Jarrett P. 2013. Scalp involvement by Sarcoptes scabiei var hominis resembling seborrhoeic dermatitis in two immunocompromised patients with systemic lupus erythematosus. The New Zealand Medical Journal 126: 75-78.
  • [13] Goldust M., Rezaee E., Raghifar R., Naghavi-Behzad M. 2013. Comparison of permethrin 2.5 % cream vs. tenutex emulsion for the treatment of scabies. Annals of Parasitology 59: 31-35.
  • [14] Gomez-Puerta L.A., Olazabal J., Taylor C.E., Cribillero N.G., Lopez-Urbina M.T., Gonzalez A.E. 2013. Sarcoptic mange in vicuna (Vicugna vicugna) population in Peru. Veterinary Record 173: 269.
  • [15] Mohebbipour A., Saleh P., Goldust M., Amirnia M., Zadeh Y.J., Mohamad R.M. et al. 2013. Comparison of oral ivermectin vs. lindane lotion 1% for the treatment of scabies. Clinical and Experimental Dermatology 38: 719-723.
  • [16] McLean F.E. 2013. The elimination of scabies: a task for our generation. International Journal of Dermatology 52: 1215-1223.
  • [17] Pourhasan A., Goldust M., Rezaee E. 2013. Treatment of scabies, permethrin 5% cream vs. crotamiton 10% cream. Annals of Parasitology 59: 143-147.
  • [18] Ranjkesh M.R., Naghili B., Goldust M., Rezaee E. 2013. The efficacy of permethrin 5% vs. oral ivermectin for the treatment of scabies. Annals of Parasitology 59: 189-194.
  • [19] Talukder K., Talukder M.Q., Farooque M.G., Khairul M., Sharmin F., Jerin I. et al. 2013. Controlling scabies in madrasahs (Islamic religious schools) in Bangladesh. Public Health 127: 83-91.
  • [20] Goldust M., Rezaee E. 2013. The efficacy of topical ivermectin versus malation 0.5% lotion for the treatment of scabies. Journal of Dermatological Treatment doi: 10.3109/09546634.2013.782093.
  • [21] Goldust M., Rezaee E., Raghifar R. 2014. Comparison of oral ivermectin versus crotamiton 10% cream in the treatment of scabies. Cutaneous and Ocular Toxicology 33: 333-336.
  • [22] Goldust M., Rezaee E., Hemayat S. 2012. Treatment of scabies: Comparison of permethrin 5% versus ivermectin. Journal of Dermatology 39: 545-547.
  • [23] Bachewar N.P., Thawani V.R., Mali S.N., Gharpure K.J., Shingade V.P., Dakhale G.N. 2009. Comparison of safety, efficacy, and cost effectiveness of benzyl benzoate, permethrin, and ivermectin in patients of scabies. Indian Journal of Pharmacology 41: 9-14.
  • [24] Ly F., Caumes E., Ndaw C.A., Ndiaye B., Mahe A. 2009. Ivermectin versus benzyl benzoate applied once or twice to treat human scabies in Dakar, Senegal: a randomized controlled trial. Bulletin of the World Health Organisation 87: 424-430.
  • [25] Steer A.C., Kearns T., Andrews R.M., McCarthy J.S., Carapetis J.R., Currie B.J. 2009. Ivermectin worthy of further investigation. Bulletin of the World Health Organisation 87(10): A.
  • [26] Nofal A. 2009. Variable response of crusted scabies to oral ivermectin: report on eight Egyptian patients. Journal of the European Academy of Dermatology and Venereology 23: 793-797.
  • [27] van den Hoek J.A., van de Weerd J.A., Baayen T.D., Molenaar P.M., Sonder G.J., van Ouwerkerk I.M. et al. 2008. A persistent problem with scabies in and outside a nursing home in Amsterdam: indications for resistance to lindane and ivermectin. Euro Surveillance 13(48).
  • [28] Twomey D.F., Birch E.S., Schock A. 2009. Outbreak of sarcoptic mange in alpacas (Vicugna pacos) and control with repeated subcutaneous ivermectin injections. Veterinary Parasitology 159: 186-191.
  • [29] Badiaga S., Foucault C., Rogier C., Doudier B., Rovery C., Dupont H.T. et al. 2008. The effect of a single dose of oral ivermectin on pruritus in the homeless. The Journal of Antimicrobial Chemo the - rapy 62: 404-409.
  • [30] Garcia C., Iglesias D., Terashima A., Canales M., Gotuzzo E. 2007. Use of ivermectin to treat an institutional outbreak of scabies in a low-resource setting. Infection Control and Hospital Epidemiology 28: 337-1338.
  • [31] Goldust M., Rezaee E., Raghifar R. 2013. Comparison of oral ivermectin versus crotamiton 10% cream in the treatment of scabies. Cutaneous and Ocular Toxicology doi:10.3109/ 15569527. 2013.768258
  • [32] Usha V., Gopalakrishnan Nair T.V. 2000. A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. Journal of the American Academy of Dermatology 42: 236- 240.
  • [33] Boussinesq M. 2005. Ivermectin. Médecine Tropicale 65: 69-79.
  • [34] Lawrence G., Leafasia J., Sheridan J., Hills S., Wate J., Wate C. et al. 2005. Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin. Bulletin of the World Health Organization 83: 34-42.
  • [35] Heukelbach J., Winter B., Wilcke T., Muehlen M., Albrecht S., de Oliveira F.A. et al. 2004. Selective mass treatment with ivermectin to control intestinal helminthiases and parasitic skin diseases in a severely affected population. Bulletin of the World Health Organization 82: 563-571.
  • [36] Speare R., Durrheim D. 2004. Mass treatment with ivermectin: an underutilized public health strategy. Bulletin of the World Health Organization 82: 562.
  • [37] Heukelbach J., Wilcke T., Winter B., Sales de Oliveira F.A., Saboia Moura R.C., Harms G. et al. 2004. Efficacy of ivermectin in a patient population concomitantly infected with intestinal helminths and ectoparasites. Arzneimittelforschung 54: 416-421.
  • [38] Develoux M. 2004. Ivermectin. Annales de Dermatologie et de Vénéréologie 131: 561-570 (In French).
  • [39] Angelo C., Pedicelli C., Provini A., Annessi G., Zambruno G., Paradisi M. 2004. Successful treatment of Norwegian scabies with ivermectin in a patient with recessive dystrophic epidermolysis bullosa. Minerva Pediatrica 56: 353-357 (In Italian).
Typ dokumentu
Bibliografia
Identyfikatory
Identyfikator YADDA
bwmeta1.element.agro-17fb4426-819a-4015-8989-6e24d3d49d04
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.